Clinical trial
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by…
NCT00127166 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00127166 |
|---|---|
| Title | Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911) |
| Official title | A Multicenter, Double-Blind, Randomized, Crossover Design Study to Evaluate the Effect of Montelukast Vs. Salmeterol on the Inhibition of Exercise-Induced Bronchoconstriction in Asthmatic Patients Aged 6-14 Years |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Exercise Induced Asthma |
| Intervention type | Drug |
| Interventions | Montelukast sodium, Salmeterol xinafoate, Fluticasone propionate, Montelukast matching placebo, Salmeterol matching placebo |
| Enrollment | 154 |
| Start date | Dec 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Aug 5, 2005 |
| Last update posted | May 10, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: